title: Pembrolizumab-induced necrotic myositis in a patient with metastatic melanoma.
authors.affiliation: Geriatric Department, Hôpitaux universitaires, Pitié-Salpêtrière Charles Foix, DHU FAST, Assistance Publique Hôpitaux de Paris (APHP), Paris Sorbonne Universités, UPMC Paris 6, UMR CNRS 8256, UMR INSERM 1166, IHU ICAN, DHU FAST, Paris.
authors.forename: H
authors.initials: H
authors.lastname: Vallet
authors.affiliation: Geriatric Department, Hôpitaux universitaires, Pitié-Salpêtrière Charles Foix, DHU FAST, Assistance Publique Hôpitaux de Paris (APHP), Paris.
authors.forename: A
authors.initials: A
authors.lastname: Gaillet
authors.affiliation: Neurological Intensive Care Unit, Neurology Department, Hôpitaux universitaires, Pitié-Salpêtrière Charles Foix, Assistance Publique Hôpitaux de Paris (APHP), Paris OncoNeuroTox Group: Center for Investigations of Patients with Neurological Complications after Cancer Treatment, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix et Val-de-Grâce, Paris.
authors.forename: N
authors.initials: N
authors.lastname: Weiss
authors.affiliation: Department of Dermatology, Hôpital Cochin, Assistance Publique Hôpitaux de Paris (APHP), Paris.
authors.forename: C
authors.initials: C
authors.lastname: Vanhaecke
authors.affiliation: Departments of Hemo-biotherapies.
authors.forename: S
authors.initials: S
authors.lastname: Saheb
authors.affiliation: Ophthalmology.
authors.forename: V
authors.initials: V
authors.lastname: Touitou
authors.affiliation: Department of Dermatology, Hôpital Cochin, Assistance Publique Hôpitaux de Paris (APHP), Paris.
authors.forename: N
authors.initials: N
authors.lastname: Franck
authors.affiliation: Department of Dermatology, Hôpital Cochin, Assistance Publique Hôpitaux de Paris (APHP), Paris.
authors.forename: N
authors.initials: N
authors.lastname: Kramkimel
authors.affiliation: Neurology 1.
authors.forename: A
authors.initials: A
authors.lastname: Borden
authors.affiliation: Neurology 2 (Mazarin), Hôpitaux universitaires, Pitié-Salpêtrière Charles Foix, Assistance Publique Hôpitaux de Paris (APHP), Paris.
authors.forename: M
authors.initials: M
authors.lastname: Touat
authors.affiliation: OncoNeuroTox Group: Center for Investigations of Patients with Neurological Complications after Cancer Treatment, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix et Val-de-Grâce, Paris Department of Neurology, Hôpital d'Instruction des Armées du Val-de-Grâce, Service de Santé des Armées, Paris Ecole du Val-de-Grâce, Service de Santé des Armées, Paris UMR 8257 MD4 COGNAC G, CNRS, Service de Santé des Armées, Université Paris-Descartes, Paris.
authors.forename: D
authors.initials: D
authors.lastname: Ricard
authors.affiliation: Geriatric Department, Hôpitaux universitaires, Pitié-Salpêtrière Charles Foix, DHU FAST, Assistance Publique Hôpitaux de Paris (APHP), Paris Sorbonne Universités, UPMC Paris 6, UMR CNRS 8256, UMR INSERM 1166, IHU ICAN, DHU FAST, Paris.
authors.forename: M
authors.initials: M
authors.lastname: Verny
authors.affiliation: Department of Clinical Neurophysiology, Hôpitaux universitaires, Pitié-Salpêtrière Charles Foix, Assistance Publique Hôpitaux de Paris (APHP), Paris.
authors.forename: T
authors.initials: T
authors.lastname: Maisonobe
authors.affiliation: OncoNeuroTox Group: Center for Investigations of Patients with Neurological Complications after Cancer Treatment, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix et Val-de-Grâce, Paris Neurology 2 (Mazarin), Hôpitaux universitaires, Pitié-Salpêtrière Charles Foix, Assistance Publique Hôpitaux de Paris (APHP), Paris UMR975 INSERM-UPMC, GH Pitié- Salpêtrière, Paris, France dimitri.psimaras@aphp.fr.
authors.forename: D
authors.initials: D
authors.lastname: Psimaras
mesh_terms: D000369:Aged, 80 and over; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000074322:Antineoplastic Agents, Immunological / Q000009:adverse effects*; D057645:Deltoid Muscle / Q000187:drug effects* / Q000473:pathology; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary; D008545:Melanoma / Q000175:diagnosis / Q000188:drug therapy*; D009220:Myositis / Q000139:chemically induced* / Q000473:pathology; D009336:Necrosis
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000074322:Antineoplastic Agents, Immunological; C582435:pembrolizumab